Asia
As opioid lawsuits continue to wind through the courts, some drugmakers are focused on developing treatments for opioid addiction.
Researchers from A*STAR’s SBIC have discovered how changes in BCAA metabolism influence the development and progression of tumours, and pave the way for new approaches to prevent and treat certain cancers
Cerner to unveil an immersive Motion Health experience and share at its booth interactive talks about the current and future health care landscape
China government officials told the Xinhua News Agency that the researcher who became world famous for using CRISPR on human embryos “will be transferred to public security authorities,” and the individuals involved in the research will be “severely dealt with according to the law.”
The U.S. Food and Drug Administration (FDA) approved South Korea’s Samsung Bioepis’ Ontruzant (trastuzumab-dttb), a biosimilar to Genentech’s Herceptin (trastuzumab).
Pharma and biotech companies make changes to their board and leadership teams to advance pipelines and strategies, at SQZ, AstraZeneca, Bioasis, and more.
Aiming at a service which prevents dementia and enables a society of healthy longevity
Food ingredient specialist Holista CollTech Ltd (ASX:HCT, “Holista”) has partnered Bursa Malaysia-listed Kawan Food Berhad (“Kawan Food”) to produce healthy Asian flatbreads, including roti canai, roti and chappati, for local and international markets.
Eisai Co., Ltd. announced today that presentations on a series of abstracts highlighting the latest data from post-hoc analyses of a Phase III clinical study (REFLECT/Study 304) on its in-house discovered multiple receptor tyrosine kinase inhibitor lenvatinib mesylate will be presented during the 2019 Gastrointestinal Cancers Symposium (ASCO-GI) in San Francisco from January 17 to 19.
Eisai Co., Ltd. and Purdue Pharma L.P. today announced that a new drug application has been submitted to the U.S. Food and Drug Administration (FDA) for lemborexant, an investigational agent for sleep-wake regulation, seeking approval for the treatment of insomnia, a sleep-wake disorder.
PRESS RELEASES